Comparison
Caffeine vs Phenylpiracetam
Caffeine
The most widely consumed psychoactive substance in human history — roughly 80% of the global population uses it daily, mostly via coffee and tea. A competitive adenosine receptor antagonist that lifts the brake on dopamine and norepinephrine signalling. The canonical pairing is 100 mg caffeine + 200 mg L-theanine for clean focus without the jitter.
Phenylpiracetam
A phenylated derivative of piracetam 20-60x more potent. Originally developed for Soviet cosmonauts.
| Field | Caffeine | Phenylpiracetam |
|---|---|---|
| Category | stimulant | racetam |
| Dose range | 50–400mg | 100–300mg |
| Half-life | 5h | 4h |
| Onset | 30min | 30min |
| Evidence | EVIDENCEA | EVIDENCEB |
| Safety | ●●●●○ | ●●●●○ |
| Legal (US) | USOTC | USUnscheduled |
| PubMed refs | 25000 | 80 |
The comparison in plain English
Auto-generated from dataCaffeine and Phenylpiracetam are both in the stimulant (stimulant) and racetam respectively. Caffeine The most widely consumed psychoactive substance in human history — roughly 80% of the global population uses it daily, mostly via coffee and tea. Phenylpiracetam A phenylated derivative of piracetam 20-60x more potent.
Bottom line
Caffeine (evidence A, safety 4/5) has a weaker evidence base than Phenylpiracetam (evidence B, safety 4/5). Caffeine has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose Caffeine if
Caffeine is the better fit when your goal aligns with its mechanism (Competitively blocks adenosine A1 and A2A receptors) and the dose range (50–400mg) suits your protocol. Half-life is 5h.
Choose Phenylpiracetam if
Phenylpiracetam is the better fit when your goal aligns with its mechanism (Modulates AMPA, NMDA, and nicotinic acetylcholine receptors and increases dopamine receptor density (D1, D2, D3) in the striatum) and the dose range (100–300mg) suits your protocol. Half-life is 4h.